Licensing Deal

Sun Pharma Signs In-licensing Deal To Sell Skincare Drug In US

September 17,2021 10:04 AM
- By Admin

The Mumbai based 

Sun Pharmaceutical Industries

 NSE 0.10 % has signed an in-licensing agreement with Italian pharmaceutical company Cassiopea SpA to sell Winlevi (clascoterone cream 1%) in the United States and Canada.

Winlevi has been approved by the United States Food & Drug Administration (FDA) as a novel drug with a unique mechanism of action for the topical treatment of acne in patients 12 years and older, according to a compa ..